Back to Authors

Kothapalli, Naga Pradyumna

Mayo Clinic

Mayo Clinic

Citations 5

Aquaporin-4 IgG Positive Neuromyelitis Optica Spectrum Disorder: Frequency and Type of Cancer Co-Existence, Antigen Expression and Proof of Paraneoplastic Phenotype (P11-8.018)
Kothapalli, Naga Pradyumna, Wingerchuk, Dean M. , Dubey, Divyanshu , Lassus, Fernando Cuascut, Patel, Hemali , Keegan, Mark , Sánchez, Cristina Valencia, Lucchinetti, Claudia F. , Pittock, Sean J, Guo, Yong , Flanagan, Eoin P. , Dubey, Divyanshu , Tisavipat, Nanthaya , Tobin, W. Oliver , Pittock, Sean J.

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000209063 Get It

Teaching Video NeuroImage: Adaptor-Related Protein-Complex-3 Subunit β-2 Immunoglobulin-G–Associated Autoimmune Ataxia
Kothapalli, Naga Pradyumna, McKeon, Andrew , Dubey, Divyanshu , Chompoopong, Pitcha , McKeon, Andrew , Dubey, Divyanshu

Neurology | March 15, 2024 | Volume: 102 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000209257 Get It

The Mayo Clinic Glial Autoimmunity study: Persistence of MOG-IgG seropositivity predicts relapse after ADEM in both children and adults (S13.004)
López‐Chiriboga, A. Sebastian , Majed, Masoud , Fryer, James P., Tillema, Jan‐Mendelt , Chen, John , Kothapalli, Naga Pradyumna, Sagen, Jessica, Gadoth, Avi , Wingerchuk, Dean M. , Lucchinetti, Claudia F. , Lennon, Vanda A. , McKeon, Andrew , Flanagan, Eoin P. , Dubey, Divyanshu , Weinshenker, Brian G. , Keegan, B. Mark , Pittock, Sean J.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s13.004 Get It

Paraneoplastic neurological syndromes: clinical presentations and management
Devine, Michelle F., Kothapalli, Naga Pradyumna, Elkhooly, Mahmoud , Dubey, Divyanshu , Dubey, Divyanshu

Therapeutic Advances in Neurological Disorders | February 1, 2021 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/1756286420985323 Get It

We provide an overview of the varied presentations of paraneoplastic neurological syndromes. We also review the onconeural antibodies and their particular oncological and neurological associations. Recognition of these syndromes and their oncological associations is crucial, as early diagnosis and management has been associated with better patient outcomes. Specific management strategies and prognosis vary widely depending on the underlying etiology. An understanding of the relevant clinical details, imaging findings, and other diagnostic information can help tailor treatment approaches. We provide an outline of the diagnostic evaluation and treatment of various paraneoplastic neurological disorders, presenting with central and/or peripheral nervous system involvement. We briefly discuss neurologic immune checkpoint inhibitor-related adverse events, which can occasionally present with paraneoplastic neurological syndrome phenotypes.